Therapeutic Asset Ratings

166 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
km-819 Parkinson Disease	FAScinate Therapeutics Inc.	P2	CCC (52)
Lu Af28996 Parkinson Disease	H. Lundbeck A/S	P2	CCC (52)
PITTSBURGH COMPOUND B UNLABELLED Parkinson Disease	Mayo Clinic	P2	CCC (52)
Hydrogen Parkinson Disease	dr. Siti Nurlaela, SpN	P2/3	CCC (52)
Oxygen Parkinson Disease	dr. Siti Nurlaela, SpN	P2/3	CCC (52)
Oxyhydrogen Nanobubble Infusion Parkinson Disease	dr. Siti Nurlaela, SpN	P2/3	CCC (52)
8-AZABICYCLO(3.2.1)OCTANE-2-CARBOXYLIC ACID, 3-(4-FLUOROPHENYL)-8-((2E)-3-IODO-2-PROPEN-1-YL)-, METHYL ESTER, (1R,2S,3S,5S)- Parkinson Disease	GE Healthcare	P2	CCC (51)
cpl500036 - high dose Parkinson Disease	Celon Pharma SA	P2	CCC (51)
cpl500036 - low dose Parkinson Disease	Celon Pharma SA	P2	CCC (51)
Glutathione Parkinson Disease	Gateway Institute for Brain Research	P2	CCC (51)
Pentoxifylline Parkinson Disease	Mostafa Bahaa	P2	CCC (51)
Pirepemat Parkinson Disease	Integrative Research Laboratories AB	P2	CCC (51)
Suvecaltamide Parkinson Disease	Jazz Pharmaceuticals	P2	CCC (51)
Talineuren Parkinson Disease	InnoMedica Schweiz AG	P2	CCC (51)
TEONANACATL Parkinson Disease	Yale University	P2	CCC (51)
tj0113 Parkinson Disease	Second Affiliated Hospital, School of Medicine, Zhejiang University	P2	CCC (51)
tr-012001 Parkinson Disease	SNLD, Ltd.	P2	CCC (51)
Vutiglabridin Parkinson Disease	Glaceum	P2	CCC (51)
Bhv-8000 Parkinson Disease	Biohaven Therapeutics Ltd.	P2/3	CCC (50)
Fexofenadine Parkinson Disease	Tanta University	P2/3	CCC (50)
Montelukast Parkinson Disease	Mostafa Bahaa	P2/3	CCC (50)
Vinpocetine Parkinson Disease	Tanta University	P2/3	CCC (50)
aav2-gdnf Parkinson Disease	AskBio Inc	P2	CCC (48)
Aci-7104.056 Parkinson Disease	AC Immune SA	P2	CCC (48)
ap-472 Parkinson Disease	Appello Pharmaceuticals, Inc.	P2	CCC (48)

Showing 51 to 75 of 166 assets

PreviousPage 3 of 7Next